|
KIF21A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.381800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.551000E-01 |
| Normal-vs-Stage2 |
5.708400E-01 |
| Normal-vs-Stage3 |
3.171400E-01 |
| Normal-vs-Stage4 |
6.159500E-02 |
| Stage1-vs-Stage2 |
8.765600E-01 |
| Stage1-vs-Stage3 |
8.675800E-01 |
| Stage1-vs-Stage4 |
2.376400E-01 |
| Stage2-vs-Stage3 |
7.890200E-01 |
| Stage2-vs-Stage4 |
2.845800E-01 |
| Stage3-vs-Stage4 |
3.735400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.597790E-01 |
| Normal-vs-AfricanAmerican |
6.667400E-01 |
| Normal-vs-Asian |
1.989760E-01 |
| Caucasian-vs-AfricanAmerican |
5.997000E-01 |
| Caucasian-vs-Asian |
8.745000E-01 |
| AfricanAmerican-vs-Asian |
5.842400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.449800E-01 |
| Normal-vs-Female |
4.010200E-01 |
| Male-vs-Female |
3.145000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.240800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.133200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.640010E-01 |
| Normal-vs-Age(81-100Yrs) |
7.626200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.952600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.404400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.675400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.284000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.910600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.514000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.327400E-01 |
| Classical-VS-Follicular |
9.140000E-01 |
| Classical-VS-Other |
4.305800E-01 |
| Classical-VS-Normal |
3.770800E-01 |
| Tall-VS-Follicular |
6.739800E-01 |
| Tall-VS-Other |
2.251600E-01 |
| Tall-VS-Normal |
9.426800E-01 |
| Follicular-VS-Other |
4.722000E-01 |
| Follicular-VS-Normal |
6.963600E-01 |
| Other-VS-Normal |
2.297800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.148620E-01 |
| Normal-vs-N1 |
8.717700E-02 |
| N0-vs-N1 |
6.195200E-01 |
|
|
